| The third international consensus definitions for sepsis and septic shock (Sepsis-3) M Singer, CS Deutschman, CW Seymour, M Shankar-Hari, D Annane, ... Jama 315 (8), 801-810, 2016 | 28396 | 2016 |
| Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 RP Dellinger, MM Levy, A Rhodes, D Annane, H Gerlach, SM Opal, ... Critical care medicine 41 (2), 580-637, 2013 | 27325* | 2013 |
| Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016 A Rhodes, LE Evans, W Alhazzani, MM Levy, M Antonelli, R Ferrer, ... Intensive care medicine 43, 304-377, 2017 | 11235 | 2017 |
| Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis American College of Chest Physicians Crit care med 20, 864-875, 1992 | 6812* | 1992 |
| A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care PC Hébert, G Wells, MA Blajchman, J Marshall, C Martin, G Pagliarello, ... New England Journal of Medicine 340 (6), 409-417, 1999 | 6246 | 1999 |
| Intensive versus conventional glucose control in critically ill patients. RJJ NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D ... New England Journal of Medicine 360 (13), 1283-1297, 2009 | 6157 | 2009 |
| 2001 sccm/esicm/accp/ats/sis international sepsis definitions conference MM Levy, MP Fink, JC Marshall, E Abraham, D Angus, D Cook, J Cohen, ... Critical care medicine 31 (4), 1250-1256, 2003 | 5999 | 2003 |
| International study of the prevalence and outcomes of infection in intensive care units JL Vincent, J Rello, J Marshall, E Silva, A Anzueto, CD Martin, R Moreno, ... Jama 302 (21), 2323-2329, 2009 | 4920 | 2009 |
| Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome JC Marshall, DJ Cook, NV Christou, GR Bernard, CL Sprung, WJ Sibbald Critical care medicine 23 (10), 1638-1652, 1995 | 4155 | 1995 |
| The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis MM Levy, RP Dellinger, SR Townsend, WT Linde-Zwirble, JC Marshall, ... Intensive care medicine 36, 222-231, 2010 | 2216 | 2010 |
| A clinical case definition of post-COVID-19 condition by a Delphi consensus JB Soriano, S Murthy, JC Marshall, P Relan, JV Diaz The Lancet infectious diseases 22 (4), e102-e107, 2022 | 2116 | 2022 |
| Critically ill patients with 2009 influenza A (H1N1) infection in Canada A Kumar, R Zarychanski, R Pinto, DJ Cook, J Marshall, J Lacroix, T Stelfox, ... Jama 302 (17), 1872-1879, 2009 | 2046 | 2009 |
| Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis JAC Sterne, S Murthy, JV Diaz, AS Slutsky, J Villar, DC Angus, D Annane, ... Jama 324 (13), 1330-1341, 2020 | 2003 | 2020 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021 | 1984 | 2021 |
| No surgical innovation without evaluation: the IDEAL recommendations P McCulloch, DG Altman, WB Campbell, DR Flum, P Glasziou, ... The Lancet 374 (9695), 1105-1112, 2009 | 1903 | 2009 |
| Drotrecogin alfa (activated) in adults with septic shock VM Ranieri, BT Thompson, PS Barie, JF Dhainaut, IS Douglas, S Finfer, ... New England Journal of Medicine 366 (22), 2055-2064, 2012 | 1556 | 2012 |
| Risk factors for gastrointestinal bleeding in critically ill patients DJ Cook, HD Fuller, GH Guyatt, JC Marshall, D Leasa, R Hall, TL Winton, ... New England journal of medicine 330 (6), 377-381, 1994 | 1512 | 1994 |
| Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit JL Vincent, JC Marshall, SA Ñamendys-Silva, B François, ... The lancet Respiratory medicine 2 (5), 380-386, 2014 | 1391 | 2014 |
| Multiple-organ-failure syndrome CJ Carrico, JL Meakins, JC Marshall, D Fry, RV Maier Archives of Surgery 121 (2), 196-208, 1986 | 1381 | 1986 |
| Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial CJ Fisher, JFA Dhainaut, SM Opal, JP Pribble, RA Balk, GJ Slotman, ... Jama 271 (23), 1836-1843, 1994 | 1359 | 1994 |
Jean-Louis VincentUniversité libre de Bruxellesכתובת אימייל מאומתת בדומיין ulb.ac.be
